The 2025 Translational Medicine Symposium is co-sponsored by the Program in Translational Medicine and the Cancer Cell Biology Training Program.  


Symposium Agenda

9:00-10:20a Welcome and Keynote Address by Dr. Jeremy Rich in MBRB G202  
10:30-11:20a  Trainee Talks and Poster Pitches in MBRB G202 
   10:30. Poster session 1 Elevator pitches  
   10:45. Trainee talk, Sy’Keria Garrison  
   11:00. Trainee talk, Coral del Mar Alicea Pauneto  
   11:15. Poster session 2 Elevator Pitches 
11:30-12:30p  Poster Session I in MBRB lobbies 1st and second floors  
12:30-1:30p  Networking Lunch in Taylor Hall 214   
1:40-2:40p  Poster session 2 in MBRB lobbies 1st and second floors  
2:45-3:30p Trainee Talks in MBRB G202
   2:45. Trainee talk, Meagan Colie  
   3:00. Trainee talk, Ryan Robb  
   3:15. Trainee talk, Gaby Soden 
3:30 – 3:45  Afternoon Break in Lobby outside MBRB G202
3:45-4:45p  Closing Keynote Address by Dr. Tracy Nolen in MBRB G202
4:45-5:00p  Closing Remarks in MBRB G202


Invited speakers:
Jeremy Rich, MD, MBA, MHS, Deputy Director for Research & Chief Scientific Officer at Lineberger Comprehensive Cancer Center. 
Dr. Rich is Deputy Director for Research and Chief Scientific Officer of the Lineberger Comprehensive Cancer Center, and Professor of Neurology at University of North Carolina, Chapel Hill. Dr. Rich’s Laboratory identifies novel therapeutic paradigms in the treatment of advanced cancers, primarily malignant brain tumors, through the prism of stem cell biology to identify core regulatory pathways amenable to pharmacologic targeting. His team aims to better understand the clinical relevance of cancer stem cells and the interaction with the tumor microenvironment and underlying genetic driver mutations in human cancers. 

Tracy Nolen, DrPh, Director of Public Health Biostatistics at RTI. 
Dr. Nolen specializes in the oversight, design, implementation, and analysis of preclinical, observational, and all-phase clinical research. She is experienced with various clinical designs, including longitudinal cohort studies, investigational new drug trials, and alternative study designs. She has worked in many therapeutic areas such as maternal and child health, neonatal health, neurotrauma, substance use disorders, infectious diseases, autoimmune diseases, endocrinology, cardiovascular disease, autism, urinary incontinence, and orthopedics.